Scancell Holdings plc is a biotechnology company focused on the development of innovative immunotherapies for the treatment of cancer. The company is engaged in creating and advancing their proprietary technology platforms, including Modi-1, a peptide-based vaccine, and other immuno-oncology treatments aimed at enhancing the immune response against tumors.